Abstract
Establishing the diagnosis of classical Hodgkin lymphoma (cHL) in a timely fashion can be a challenge, as there are no pathognomonic signs or symptoms. The percutaneous needle biopsy (CNB) of the tumor gained increased popularity due to its minimal invasiveness and expeditious recovery from procedure. The diagnostic accuracy of CNB depends upon patient size, mass accessibility, and feasibility to obtain diagnostic tissue assuming that the tumor is histologically homogenous. We report on a patient with cHL who underwent multiple CNB from different sites before the diagnosis was established. Yet, only the incisional biopsy of the most metabolically-active tumor site resulted in diagnostic success. It is imperative to thoroughly consider both the biopsy method and the biopsy site for establishing correct diagnosis.
Original language | English (US) |
---|---|
Pages (from-to) | 81-83 |
Number of pages | 3 |
Journal | Pediatric Hematology Oncology Journal |
Volume | 6 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2021 |
Externally published | Yes |
Keywords
- Classical Hodgkin lymphoma
- Core needle biopsy
- Cystic thymus
- Open biopsy
ASJC Scopus subject areas
- Hematology
- Oncology
- Pediatrics, Perinatology, and Child Health